Olympus Sells Scientific Solutions Business to Focus on MedTech Business

Olympus Corporation announces that it is to transfer the Scientific Solutions Business to Bain Capital for JPY 427,674 million (US$ 3.1 billion).

Early in November 2019, Olympus announced its new corporate strategy to achieve sustainable growth as a global medical technology company, allocating management resources actively to the medical business with a focus on the Endoscopic Solutions Business and Therapeutic Solutions Business.

Olympus’ Scientific Solutions Business covers the solutions for biological microscopes, industrial microscopes, industrial endoscopes, non-destructive testing equipment, and X-ray analyzers.

For its 2022 fiscal year ending March 31, Scientific Solutions Business contributed revenues of JPY 119.1 billion (US$860 million) to the group, with an operating profit of JPY 17.5 billion (US$126 million).